Trial
NCT00924287
Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Metastatic Cancer
Intervention
in vitro tumor reactive, chimeric T cell receptor (CAR ) gene-transduced PBL plus IV aldesleukin
Why stopped
This study was terminated after the first patient treated on study died as a result of the treatment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-28